Latest News

Recommendations From a Pediatric Dermatologist on Using AI in Daily Practice


 

FROM SPD 2024

AI Hallucinations

Dr. Yan broached an issue that occasionally comes up, AI hallucinations, which refer to inaccurate or misleading responses on the basis of incomplete training or intrinsic biases within the model. He pointed to the case of a doctor discussing issues related to a patient’s hands, feet, and mouth, which the AI-generated model summarized as “the patient being diagnosed with hand, foot, and mouth disease.”

Another example he provided was a request to generate a letter of medical necessity for using ustekinumab (Stelara) for treating hidradenitis suppurative in a child that included references for its effectiveness and safety in children. The AI system generated “false references that sounded like they should be real because the authors are often people who have written in that field or on that subject,” said Dr. Yan.

When pressed, the system did acknowledge the references were hypothetical but were meant to illustrate the types of studies that would typically support the use of this drug in pediatric patients with HS. “ It’s well meaning, in the sense that it’s trying to help you achieve your goals using this training system,” said Dr. Yan.

“If you’re skeptical about a response, double-check the answer with a Google search or run the response through another AI [tool] asking it to check if the response is accurate,” he added.

While AI systems won’t replace the clinician, they are continuing to improve and becoming more sophisticated. Dr. Yan advises keeping up with emerging developments and engaging and adapting the most appropriate AI tool for an individual clinician’s work.

Asked to comment on the presentation at the SPD meeting, Sheilagh Maguiness, MD, director of the Division of Pediatric Dermatology at the University of Minnesota, Minneapolis, who, like other doctors, is increasingly testing AI, said she foresees a time when AI scribes fully replace humans for completing tasks during patient interactions.

“The hope is that if the AI scribes get good enough, we can just open our phone, have them translate the interaction, and create the notes for us.”

While she likes the idea of using ChatGPT to help with tasks like letters of recommendation for medications, Dr. Yan’s comments reiterated the importance of “checking and double-checking ChatGPT because it’s not correct all the time.” She particularly welcomed the advice “that we can just go back and ask it again to clarify, and that may improve its answers.”

Dr. Yan’s disclosures included an investment portfolio that includes companies working in the AI space, including Google, Apple, Nvidia, Amazon, Microsoft, and Arm. Dr. Maguiness had no relevant disclosures.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Primary Care Internal Medicine Is Dead
MDedge Rheumatology
Healthcare Workers Face Gender-Based Violence
MDedge Rheumatology
Push, Fail, Push Harder: Olympic Athletes Who Became MDs
MDedge Rheumatology
Doctor on Death Row: Ahmad Reza Djalali Begins Hunger Strike
MDedge Rheumatology
The Rise of the Scribes
MDedge Rheumatology
Fed Worker Health Plans Ban Maximizers and Copay Accumulators: Why Not for the Rest of the US?
MDedge Rheumatology
A Guide to Eating Healthy While Working in Healthcare
MDedge Rheumatology
Insurers’ Rules and AI for Preauthorization: ‘Ethically Nuts,’ Says Ethicist
MDedge Rheumatology
SUNY Downstate Emergency Medicine Doc Charged With $1.5M Fraud
MDedge Rheumatology
Government Accuses Health System of Paying Docs Outrageous Salaries for Patient Referrals
MDedge Rheumatology